First trimester intact hCG as an early marker of trisomy 21: A promise unrecognised?

Prenatal Diagnosis

Volumn 28, Issue 12, 2008, Pages 1156-1159

  Spencer, Kevin ^a,b   Cowans, Nicholas J ^a   Uldbjerg, Niels ^c   Vereecken, Annie ^d   Tørring, Niels ^c  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Algemeen Medisch Laboratorium   (Belgium)

Author keywords

Aneuploidy; Free hCG; Intact hCG; NT; PAPP A; Prenatal screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 21;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MOTHERS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

EID: 57149109376     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2148     Document Type: Article

References (12)

1. Canick JA, Palomaki GE, Osanthonondh R. 1990. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 10: 546-548.
2. Gyselaers W, Vereecken A, Van Herck E, et al. 2005. Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol. Prenat Diagn 25: 984-990.
3. Office for National Statistics. 2006. Birth Statistics, Series FM1, No. 33. Stationery Office: London.
4. Royston P, Thompson SG. 1992. Model based screening for risk with application to Down's syndrome. Stat Med 11: 257-268.
5. Schiott KM, Christiansen M, Petersen OB, Sorensen TL, Uldbjerg N. 2006. The "Consecutive Combined Test" - using Double Test from week 8 + 0 and Nuchal Translucency Scan, for first trimester screening for Down Syndrome. Prenat Diagn 26: 1105-1109.
6. Snijders RMJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. 1999. Maternal age and gestation specific risk for trisomy 21. Ultrasound Obstet Gynecol 13: 167-170.
7. Spencer K, Berry E, Crossley JA, Aitken DA, Nicolaides KH. 2000. Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy. Prenat Diagn 20: 311-317.
8. Spencer K, Crossley JA, Aitken DA, Nix ABJ, Dunstan FDJ, Williams K. 2002. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 39: 567-576.
9. Spencer K, Crossley JA, Aitken DA, Nix ABJ, Dunstan FDJ, Williams K. 2003. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome. Ann Clin Biochem 40: 219-231.
10. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy associated plasma protein -A. Ultrasound Obstet Gynaecol 13: 231-237.
11. Wald NJ, Kennard A, Hackshaw A, McGuire A. 1998. Antenatal screening for Down's syndrome. Health Technol Assess 2(1).
12. Wright D, Spencer K, Nix B. 2007. First trimester screening for Down syndrome using free β hCG, total hCG and PAPP-A: an exploratory study. Prenat Diagn 27: 1118-1122.